[1] Cunningham RL.Mechanism and clinical aspects of chronic arterial hypertension[J]. Cal State J Med,1912, 10(7):303-305.
[2] The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure[J]. Arch Intern Med,1988,148(5):1023-1038.
[3] Mancia G, De Backer G, Dominiczak A, et al.2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology(ESC)[J]. J Hypertens,2007,25(6):1105-1187.
[4] Mancia G, Fagard R, Narkiewicz K, et al.2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)[J]. J Hypertens,2013,31(7):1281-1357.
[5] James PA, Oparil S, Carter BL, et al.2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA,2014,311(5):507-520.
[6] 施仲伟. 我看JNC 8:没了名分成绝唱, 有些底气靠质量[M]//葛均波, 方唯一, 沈卫峰. 现代心脏病学进展2014. 1版. 上海: 复旦大学出版社,2014:45-47.
[7] Qaseem A, Wilt TJ, Rich R, et al.Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians[J]. Ann Intern Med,2017,166(6):430-437.
[8] Wright JT Jr, Fine LJ, Lackland DT, et al.Evidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: the minority view[J]. Ann Intern Med,2014,160(7):499-503.
[9] Borden WB, Maddox TM, Tang F, et al.Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry[J]. J Am Coll Cardiol,2014,64(21):2196-2203.
[10] Ambrosius WT, Sink KM, Foy CG, et al.The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial(SPRINT)[J]. Clin Trials,2014,11(5):532-546.
[11] SPRINT Research Group, Wright JT Jr, Williamson JD, et al.A Randomized Trial of Intensive versus Standard Blood-Pressure Control[J]. N Engl J Med,2015,373(22):2103-2116.
[12] Verdecchia P, Angeli F, Reboldi G.The SPRINT trial[J]. J Am Soc Hypertens,2015,9(10):750-753.
[13] National Institutes of Health. Landmark NIH study shows intensive blood pressure management may save lives: lower blood pressure target greatly reduces cardiovascular complications and deaths in older adults[R].2017-10-26[2017-11-02].https://www.nih.gov/news-events/news-releases/landmark-nih-study-shows-intensive-blood-pressure-mana-gement-may-save-lives.
[14] Williamson JD, Supiano MA, Applegate WB, et al.Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial[J]. JAMA,2016,315(24):2673-2682.
[15] Phillips RA.Current and future treatment of hypertension in the SPRINT Era[J]. Methodist Debakey Cardiovasc J,2015,11(4):206-213.
[16] Tsioufis C, Tousoulis D.SPRINT Results Are Life-Saving, Guideline-Changing, and Hypertension Research-Intensifying[J]. Hellenic J Cardiol,2015,56(6):529-530.
[17] Leung AA, Daskalopoulou SS, Dasgupta K, et al.Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults[J]. Can J Cardiol,2017,33(5):557-576.
[18] Gabb GM, Mangoni AA, Anderson CS, et al.Guideline for the diagnosis and management of hypertension in adults-2016[J]. Med J Aust,2016,205(2):85-89.
[19] Fuster V.No Such thing as ideal blood pressure: A case for personalized medicine[J]. J Am Coll Cardiol,2016,67(25):3014-3015.
[20] Filippone EJ, Foy AJ.Blood pressure management in the wake of SPRINT[J]. Cleve Clin J Med,2016,83(3):196-198.
[21] Esler M.SPRINT, or False Start, Toward a lower universal treated blood pressure target in hypertension[J]. Hypertension,2016,67(2):266-267.
[22] Franklin SS, Jacobs MJ, Wong ND, et al.Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey(NHANES) Ⅲ[J]. Hypertension,2001,37(3):869-874.
[23] Thomopoulos C, Parati G, Zanchetti A.Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials[J]. J Hypertens,2014,32(12):2285-2295.
[24] Kjeldsen SE, Narkiewicz K, Hedner T, et al.The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg[J]. Blood Press,2016,25(2):63-66.
[25] Lonn EM, Yusuf S.Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? An antagonist view from the HOPE-3 Trial(Heart Outcomes Evaluation-3)[J]. Circulation,2016,134(18):1311-1313.
[26] Myers MG, Godwin M, Dawes M, et al.Measurement of blood pressure in the office: recognizing the problem and proposing the solution[J]. Hypertension,2010,55(2):195-200.
[27] Kjeldsen SE, Lund-Johansen P, Nilsson PM, et al.Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials[J]. Hypertension,2016,67(5):808-812.
[28] Myers MG, Campbell NR.Unfounded concerns about the use of automated office blood pressure measurement in SPRINT[J]. J Am Soc Hypertens,2016,10(12):903-905.
[29] Bundy JD, Li C, Stuchlik P, et al.Systolic blood pressure reduction and risk of cardiovascular disease and mortality: A systematic review and network meta-analysis[J]. JAMA Cardiol,2017,2(7):775-781.
[30] Tsai WC, Wu HY, Peng YS, et al.Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: A systematic review and meta-analysis[J]. JAMA Intern Med,2017,177(6):792-799.
[31] Bakris GL.The Implications of blood pressure measurement methods on treatment targets for blood pressure[J]. Circulation,2016,134(13):904-905.
[32] Bakris G.Response by Bakris to letter regarding article, "The implications of blood pressure measurement metho-ds on treatment targets for blood pressure"[J]. Circulation,2017,135(7):e47.
[33] Cushman WC, Whelton PK, Fine LJ, et al.SPRINT Trial results: Latest news in hypertension management[J]. Hypertension,2016,67(2):263-265.
[34] Cushman WC, Evans GW, Rodriguez CJ, et al.Blood pressure intervention and control in the systolic blood pressure intervention trial (SPRINT)[J]. J Am Soc Hypertens,2016,10(4S):e4.
[35] Myers MG, Valdivieso M, Kiss A.Use of automated office blood pressure measurement to reduce the white coat response[J]. J Hypertens,2009,27(2):280-286.
[36] Agarwal R. Implications of blood pressure measurement technique for implementation of Systolic Blood Pressure Intervention Trial(SPRINT)[J]. J Am Heart Assoc,2017,6(2),pii:e004536.
[37] Filipovsky J, Seidlerová J, Kratochvíl Z, et al.Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients[J]. Blood Press,2016,25(4):228-234.
[38] 施仲伟. 美国胆固醇指南和高血压指南批评声音略显嘈杂[J]. 诊断学理论与实践,2014,13(1):39-43.
[39] Schiffrin EL, Calhoun DA, Flack JM.Do We Need a New Definition of Hypertension After SPRINT?[J]. Am J Hypertens,2016,29(10):1127-1129.
[40] ACCORD Study Group, Cushman WC, Evans GW, et al.Effects of intensive blood-pressure control in type 2 diabetes mellitus[J]. N Engl J Med,2010,362(17):1575-1585.
[41] Lonn EM, Bosch J, López-Jaramillo P, et al.Blood-Pressure lowering in intermediate-risk persons without cardiovascular disease[J]. N Engl J Med,2016,374(21):2009-2020.
[42] Elgendy IY, Bavry AA, Gong Y, et al.Long-term mortality in hypertensive patients with coronary artery disease: Results from the US Cohort of the International Verapamil (SR)/Trandolapril Study[J]. Hypertension,2016,68(5):1110-1114.
[43] Mancia G, Kjeldsen SE, Zappe DH, et al.Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial[J]. Eur Heart J,2016,37(12):955-964.
[44] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志,2011,39(7):579-616.
